ESC 365 - Long-term management of patients with ATTR-CM.

Open Access

Long-term management of patients with ATTR-CM.

Session: Looking beyond heart failure: could it be transthyretin amyloid cardiomyopathy (ATTR-CM)?

Topic: Cardiac Diseases

Speaker: Professor C. Rapezzi (Ferrara, IT)

Sponsored by Pfizer

Event: Heart Failure 2022

Congress Presentation

Add to my library

About the speaker

Professor Claudio Rapezzi

University of Ferrara, Ferrara (Italy)

29 presentations

3 followers

3 more presentations in this session

Heart failure or ATTR-CM? The importance of early diagnosis.

Speaker: Doctor J. Gonzalez-Costello (Hospitalet De Llobregat, ES)

Clinical perspectives: raising suspicion and diagnosing ATTR-CM in patients with heart failure.

Speaker: Associate Professor A. Pollak (Jerusalem, IL)

Panel discussion and Q&A.

Access the full session

Looking beyond heart failure: could it be transthyretin amyloid cardiomyopathy (ATTR-CM)?

Speakers: Professor C. Rapezzi, Doctor J. Gonzalez-Costello, Associate Professor A. Pollak

About the event

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources